Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis.

× No keyword cloud information.

11 in total

1. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors: G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal: Calcif Tissue Int Date: 1986-01 Impact factor: 4.333

Review 2. [Problems in calcitonin research].

Authors: H G Haas; M A Dambacher; J Guncaga; T Lauffenburger; C Lentner
Journal: Klin Wochenschr Date: 1972-01-01

3. Calcitonin treatment in Ekman-Lobstein disease.

Authors: A Caniggia; C Gennari
Journal: Calcif Tissue Res Date: 1972

4. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.

Authors: A Long; T Loughlin; R P Towers; T J McKenna
Journal: Ir J Med Sci Date: 1988-07 Impact factor: 1.568

5. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.

Authors: C Gennari; D Agnusdei; A Camporeale
Journal: Osteoporos Int Date: 1993 Impact factor: 4.507

6. Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.

Authors: L V Avioli
Journal: Endocrine Date: 1996-10 Impact factor: 3.633

7. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors: R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal: J Clin Invest Date: 1988-10 Impact factor: 14.808

Review 8. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.

Authors: C Gennari; R Nuti; D Agnusdei; A Camporeale; G Martini
Journal: Drug Saf Date: 1994-09 Impact factor: 5.606

Review 9. Pharmacology and therapeutic use of calcitonin.

Authors: J C Stevenson; I M Evans
Journal: Drugs Date: 1981-04 Impact factor: 9.546

10. The 24-h urinary cyclic adenosine 3', 5' monophosphate/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function.

Authors: A Caniggia; R Nuti; M Galli
Journal: J Endocrinol Invest Date: 1981 Jul-Sep Impact factor: 4.256